197
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Use of endoscopic assessment of gastric atrophy for gastric cancer risk stratification to reduce the need for gastric mapping

ORCID Icon, , , &
Pages 402-407 | Received 10 Oct 2019, Accepted 01 Mar 2020, Published online: 28 Mar 2020

References

  • Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis. 2012;13(1):2–9.
  • de Vries AC, van Grieken NC, Looman CW, et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology. 2008;134:945–952.
  • Song H, Ekheden IG, Zheng Z, et al. Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population. BMJ. 2015;351:h3867
  • Yue H, Shan L, Bin L. The significance of OLGA and OLGIM staging systems in the risk assessment of gastric cancer: a systematic review and meta-analysis. Gastric Cancer. 2018;21(4):579–587.
  • Rugge M, Genta RM, Fassan M, et al. OLGA gastritis staging for the prediction of gastric cancer risk: a long-term follow-up study of 7436 patients. Am J Gastroenterol. 2018;113(11):1621–1628.
  • Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64(9):1353–1367.
  • Pimentel-Nunes P, Libanio D, Marcos-Pinto R, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. 2019;51:365–388.
  • Kaji K, Hashiba A, Uotani C, et al. Grading of atrophic gastritis is useful for risk stratification in endoscopic screening for gastric cancer. Am J Gastroenterol. 2019;114(1):71–79.
  • Shichijo S, Hirata Y, Niikura R, et al. Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication. Gastrointest Endosc. 2016;84(4):618–624.
  • World Cancer Research Fund. 2018. Available from: https://www.wcrf.org/dietandcancer/cancer-trends/stomach-cancer-statistics.
  • Quach DT, Le HM, Hiyama T, et al. Relationship between endoscopic and histologic gastric atrophy and intestinal metaplasia. Helicobacter. 2013;18(2):151–157.
  • Quach DT, Le HM, Nguyen TS, et al. The Distribution of Incomplete Gastric Intestinal Metaplasia (GIM) subtype among biopsy sites according to the updated sydney system and its association with GIM extension. Gastroenterol Res Pract. 2018;2018:4938730.
  • Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy. 1969;1 (03):87–97.
  • Quach DT, Hiyama T. Assessment of endoscopic gastric atrophy according to the Kimura-Takemoto classification and its potential application in daily practice. Clin Endosc. 2019;52(4):321–327.
  • Rugge M, Correa P, Di Mario F, et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis. 2008;40(8):650–658.
  • Dixon MF. Gastrointestinal epithelial neoplasia: Vienna revisited. Gut. 2002;51(1):130–131.
  • Majima A, Handa O, Naito Y, et al. Early-stage gastric cancer can be found in improved atrophic mucosa over time from successful Helicobacter pylori eradication. Digestion. 2017;95(3):194–200.
  • Toyoshima O, Yamaji Y, Yoshida S, et al. Endoscopic gastric atrophy is strongly associated with gastric cancer development after Helicobacter pylori eradication. Surg Endosc. 2017;31(5):2140–2148.
  • Tahara T, Shibata T, Horiguchi N, et al. A possible link between gastric mucosal atrophy and gastric cancer after Helicobacter pylori eradication. PLoS One. 2016;11(10):e0163700.
  • Rugge M, Sacchi D, Graham DY, et al. Secondary prevention of gastric cancer: merging the endoscopic atrophic border with OLGA staging. Gut. 2019. DOI:10.1136/gutjnl-2019-319107
  • Quach DT, Hiyama T, Gotoda T. Do subjects with mild or moderate atrophic gastritis or intestinal metaplasia confined to the antrum benefit from gastric cancer surveillance? Gut. 2019. DOI:10.1136/gutjnl-2019-318720
  • Quach DT, Vilaichone R-k, Vu KV, et al. Helicobacter pylori infection and related gastrointestinal diseases in Southeast Asian countries: an expert opinion survey. Asian Pac J Cancer Prev. 2018;19(12):3565–3569.
  • Gonzalez CA, Sanz-Anquela JM, Gisbert JP, et al. Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence. Int J Cancer. 2013;133(5):1023–1032.
  • Kim Y-I, Kook M-C, Cho S-J, et al. Effect of biopsy site on detection of gastric cancer high-risk groups by OLGA and OLGIM stages. Helicobacter. 2017;22(6):e12442.
  • Naylor GM, Gotoda T, Dixon M, et al. Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients. Gut. 2006;55(11):1545–1552.
  • Castro R, Esposito G, Libânio D, et al. A single vial is enough in the absence of endoscopic suspected intestinal metaplasia – less is more! Scand J Gastroenterol. 2019;54(5):673–677.
  • Marcos P, Brito-Gonçalves G, Libânio D, et al. Endoscopic grading of gastric intestinal metaplasia on risk assessment for early gastric neoplasia: can we replace histology assessment also in the West? Gut. 2020. DOI:10.1136/gutjnl-2019-320091
  • Miwata T, Quach DT, Hiyama T, et al. Interobserver and intraobserver agreement for gastric mucosa atrophy. BMC Gastroenterol. 2015;15(1):95.
  • Jin EH, Chung SJ, Lim JH, et al. Training effect on the inter-observer agreement in endoscopic diagnosis and grading of atrophic gastritis according to level of endoscopic experience. J Korean Med Sci. 2018;33(15):e117.
  • Chiu PWY, Uedo N, Singh R, et al. An Asian consensus on standards of diagnostic upper endoscopy for neoplasia. Gut. 2019;68(2):186–197.
  • Kodama M, Okimoto T, Ogawa R, et al. Endoscopic atrophic classification before and after H. pylori eradication is closely associated with histological atrophy and intestinal metaplasia. Endosc Int Open. 2015;03:E311–E317.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.